Xin-Ru Wang1,2,3†Shan-Shan Huang1†
Meng Wang1†
Jin-Hong Lin4Jian-Tao Wang1Jiao-Qi Ren1
Cheng-Feng He2
Wen-Jiao Xue3Yin Wang1Xue-Chun Wang1Yan-Li Zhang1Ji-Chang Xiao4*
Jing-Chun Guo2*
Hou-Guang Zhou1*- 1Department of Geriatric Neurology of Huashan Hospital, National Clinical Research Center for Aging and Medicine, Fudan University, Shanghai, China
- 2Department of Translational Neuroscience, Jing'an District Centre Hospital of Shanghai, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai, China
- 3Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China
- 4Key Laboratory of Organofluorine Chemistry, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China
A Correction on
S-9-PAHSA ameliorates cognitive decline in a type 2 diabetes mouse model by inhibiting oxidative stress and apoptosis via CAIII modulation
by Wang, X.-R., Huang, S.-S., Wang, M., Lin, J.-H., Wang, J.-T., Ren, J.-Q., He, C.-F., Xue, W.-J., Wang, Y., Wang, X.-C., Zhang, Y.-L., Xiao. J.-C., Guo, J.-C., and Zhou, H.-G. (2025). Front. Mol. Neurosci. 18:1617543. doi: 10.3389/fnmol.2025.1617543
In the published article, the equal contribution note and symbol (†) were erroneously omitted. The author list was incorrectly displayed as “Xin-Ru Wang1,2,3, Shan-Shan Huang1, Meng Wang1, Jin-Hong Lin4, Jian-Tao Wang1, Jiao-Qi Ren1, Cheng-Feng He2, Wen-Jiao Xue3, Yin Wang1, Xue-Chun Wang1, Yan-Li Zhang1, Ji-Chang Xiao4*, Jing-Chun Guo2* and Hou-Guang Zhou1*”.
The corrected author list appears below, with Xin-Ru Wang, Shan-Shan Huang and Meng Wang indicated as having equal contribution with the symbol “†”.
“Xin-Ru Wang1,2,3†, Shan-Shan Huang1†, Meng Wang1†, Jin-Hong Lin4, Jian-Tao Wang1, Jiao-Qi Ren1, Cheng-Feng He2, Wen-Jiao Xue3, Yin Wang1, Xue-Chun Wang1, Yan-Li Zhang1, Ji-Chang Xiao4*, Jing-Chun Guo2* and Hou-Guang Zhou1*”.
†These authors have contributed equally to this work
The original version of this article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: S-9-PAHSA, diabetes-associated cognitive disorder, oxidative stress, mitochondrial dysfunction, CAIII
Citation: Wang X-R, Huang S-S, Wang M, Lin J-H, Wang J-T, Ren J-Q, He C-F, Xue W-J, Wang Y, Wang X-C, Zhang Y-L, Xiao J-C, Guo J-C and Zhou H-G (2025) Correction: S-9-PAHSA ameliorates cognitive decline in a type 2 diabetes mouse model by inhibiting oxidative stress and apoptosis via CAIII modulation. Front. Mol. Neurosci. 18:1688881. doi: 10.3389/fnmol.2025.1688881
Received: 19 August 2025; Accepted: 25 August 2025;
Published: 09 September 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Wang, Huang, Wang, Lin, Wang, Ren, He, Xue, Wang, Wang, Zhang, Xiao, Guo and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hou-Guang Zhou, emhnNzM3NkAxNjMuY29t; Jing-Chun Guo, amluZ2NodW5ndW9Ac2htdS5lZHUuY24=; Ji-Chang Xiao, amNoeGlhb0BzaW9jLmFjLmNu
†These authors have contributed equally to this work